BASDAI, Bath ankylosing spondylitis disease activity index

How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?
Annelies Boonen, Désirée van der Heijde, Robert Landewé, Astrid van Tubergen, Herman Mielants, Maxime Dougados, Sjef van der Linden

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 771-777; DOI: 10.1136/ard.2006.060384
Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis
V P van Halm, J C van Denderen, M J L Peters, J W R Twisk, M van der Paardt, I E van der Horst-Bruinsma, R J van de Stadt, M H M T de Koning, B A C Dijkmans, M T Nurmohamed

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1473-1477; DOI: 10.1136/ard.2005.050443
Determinants of hyperkyphosis in patients with ankylosing spondylitis
D Vosse, D van der Heijde, R Landewé, P Geusens, H Mielants, M Dougados, S van der Linden

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 770-774; DOI: 10.1136/ard.2005.044081
Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis
E Jaakkola, I Herzberg, K Laiho, M C N M Barnardo, J J Pointon, M Kauppi, K Kaarela, E Tuomilehto-Wolf, J Tuomilehto, B P Wordsworth, M A Brown

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 775-780; DOI: 10.1136/ard.2005.041103
Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis
J C van Denderen, M van der Paardt, M T Nurmohamed, Y M M A de Ryck, B A C Dijkmans, I E van der Horst-Bruinsma

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1761-1764; DOI: 10.1136/ard.2005.036491
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks
J C Davis, D M van der Heijde, J Braun, M Dougados, J Cush, D Clegg, R D Inman, A Kivitz, L Zhou, A Solinger, W Tsuji

Annals of the Rheumatic Diseases Nov 2005, 64 (11) 1557-1562; DOI: 10.1136/ard.2004.035105
Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis
L Gossec, D van der Heijde, A Melian, D A Krupa, M K James, P F Cavanaugh, A S Reicin, M Dougados

Annals of the Rheumatic Diseases Nov 2005, 64 (11) 1563-1567; DOI: 10.1136/ard.2004.029611
Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study
H Marzo-Ortega, D McGonagle, S Jarrett, G Haugeberg, E Hensor, P O’Connor, A L Tan, P G Conaghan, A Greenstein, P Emery

Annals of the Rheumatic Diseases Nov 2005, 64 (11) 1568-1575; DOI: 10.1136/ard.2004.022582
Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment
K Briot, P Garnero, A Le Henanff, M Dougados, C Roux

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1137-1140; DOI: 10.1136/ard.2004.028670
Is avoidant coping independent of disease status and stable over time in patients with ankylosing spondylitis?
A Boonen, D van der Heijde, R Landewé, A Chorus, W van Lankveld, H Miedema, H van der Tempel, S van der Linden

Annals of the Rheumatic Diseases Oct 2004, 63 (10) 1264-1268; DOI: 10.1136/ard.2003.012435

Log in using your username and password

Main menu

Log in using your username and password

You are here

BASDAI, Bath ankylosing spondylitis disease activity index